Cytokinetics (CYTK) Cash from Investing Activities (2016 - 2025)
Historic Cash from Investing Activities for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to $110.9 million.
- Cytokinetics' Cash from Investing Activities rose 23617.69% to $110.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$553.1 million, marking a year-over-year decrease of 33117.66%. This contributed to the annual value of -$553.1 million for FY2024, which is 33117.66% down from last year.
- According to the latest figures from Q4 2024, Cytokinetics' Cash from Investing Activities is $110.9 million, which was up 23617.69% from -$45.1 million recorded in Q3 2024.
- In the past 5 years, Cytokinetics' Cash from Investing Activities registered a high of $165.5 million during Q1 2023, and its lowest value of -$651.5 million during Q2 2024.
- In the last 5 years, Cytokinetics' Cash from Investing Activities had a median value of $24.1 million in 2021 and averaged -$46.0 million.
- Its Cash from Investing Activities has fluctuated over the past 5 years, first skyrocketed by 135178.89% in 2020, then tumbled by 111832.83% in 2022.
- Cytokinetics' Cash from Investing Activities (Quarter) stood at -$173.6 million in 2020, then soared by 127.26% to $47.3 million in 2021, then tumbled by 38.21% to $29.2 million in 2022, then crashed by 378.34% to -$81.4 million in 2023, then soared by 236.18% to $110.9 million in 2024.
- Its Cash from Investing Activities stands at $110.9 million for Q4 2024, versus -$45.1 million for Q3 2024 and -$651.5 million for Q2 2024.